Evidence map›Paper›PMID 29187162›Full record

ArticleBMC cancer2017

Isolation and characterization of a new naturally immortalized human breast carcinoma cell line, KAIMRC1.

Rizwan Ali, Nosaibah Samman, Hajar Al Zahrani, Atef Nehdi, Sabhi Rahman, Abdul Latif Khan, Mohamed Al Balwi, Lolwah Abdullah Alriyees, Manal Alzaid, Ahmed Al Askar and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Pharmacological Profiling ofJournal of Cancer · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Silver Nanoparticles Formation byNanomaterials (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Rizwan AliMedical Research Core Facility and Platforms (MRCFP), King Abdullah International Medical Research Center (KAIMRC), National Guard Health Affairs (NGHA), P.O. Box 22490, Riyadh, 11426, Saudi Arabia.
Nosaibah SammanMedical Research Core Facility and Platforms (MRCFP), King Abdullah International Medical Research Center (KAIMRC), National Guard Health Affairs (NGHA), P.O. Box 22490, Riyadh, 11426, Saudi Arabia.
Hajar Al ZahraniMedical Research Core Facility and Platforms (MRCFP), King Abdullah International Medical Research Center (KAIMRC), National Guard Health Affairs (NGHA), P.O. Box 22490, Riyadh, 11426, Saudi Arabia.
Atef NehdiMedical Research Core Facility and Platforms (MRCFP), King Abdullah International Medical Research Center (KAIMRC), National Guard Health Affairs (NGHA), P.O. Box 22490, Riyadh, 11426, Saudi Arabia.
Sabhi RahmanMedical Research Core Facility and Platforms (MRCFP), King Abdullah International Medical Research Center (KAIMRC), National Guard Health Affairs (NGHA), P.O. Box 22490, Riyadh, 11426, Saudi Arabia.
Abdul Latif KhanDepartment of Pathology and Laboratory Medicine, King Abdullah Medical City (KAMC), NGHA, Riyadh, 11426, Saudi Arabia.
Mohamed Al BalwiDepartment of Pathology and Laboratory Medicine, King Abdullah Medical City (KAMC), NGHA, Riyadh, 11426, Saudi Arabia.
Lolwah Abdullah AlriyeesDepartment of Surgery, KAMC, NGHA, Riyadh, 11426, Saudi Arabia.
Manal AlzaidDepartment of Surgery, KAMC, NGHA, Riyadh, 11426, Saudi Arabia.
Ahmed Al AskarKing Abdullah International Medical Research Center/ King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City (KAMC), NGHA, Riyadh, 11426, Saudi Arabia.
Mohamed BoudjelalMedical Research Core Facility and Platforms (MRCFP), King Abdullah International Medical Research Center (KAIMRC), National Guard Health Affairs (NGHA), P.O. Box 22490, Riyadh, 11426, Saudi Arabia. boudjelalmo@ngha.med.sa.
King Abdulaziz Medical City · SAKing Abdullah Medical City · SANational Guard Health Affairs · SAKing Saud bin Abdulaziz University for Health Sciences · SA

Funding

King Abdullah International Medical Research Center RC13/267
6 · The paper itself

Abstract

backgroundBreast cancer is one of the most common cancer and a leading cause of death in women. Up to date the most commonly used breast cancer cell lines are originating from Caucasians or Afro-Americans but rarely cells are being derived from other ethnic groups. Here we describe for the first time the establishment of a naturally transformed breast cancer cell line, KAIMRC1 from an Arab woman of age 62 suffering from stage IIB breast cancer (T2N1M0). Moreover, we have characterized these cells for the biological and molecular markers, induction of MAPK pathways as well as its response to different commercially available drugs and compounds.

methodsBreast cancer tissue sections were minced and cultured in media for several weeks. KAIMRC1 cells were successfully isolated from one of the primary breast tumor tissue cultures without any enzymatic digestion. To study the growth characteristics of the cells, wound healing assay, clonogenic assay, cell proliferation assays and live cell time-lapse microscopy was performed. Karyotyping, Immunophenotyping and molecular pathway specific compound treatment was also performed. A selective breast cancer gene expression panel was used to identify genes involved in the signal transduction dysregulation and malfunction of normal biological processes during breast carcinogenesis.

resultsThese cells are ER/PR-positive and HER2-negative. The epithelial nature of these cells was confirmed by flow cytometry analysis using epithelial cell markers. They are cuboidal in shape and relatively smaller in size as compared to established cell lines, MCF-7, MDA MB-231 and the normal breast cell line, MCF-10A. In normal cell culture conditions these cells showed the capability of growing both in monolayer as well as in 3-D conformation. They showed a doubling time in vitro of approximately 24 h. They exhibit a modal karyotype of 58-63,X with abnormalities in a couple of chromosomes. KAIMRC1 cells were found to be more responsive to drug treatment in vitro in comparison to the established MDA MB-231 and MCF-7 cell lines.

conclusionsIn conclusion we have isolated and characterized a new naturally immortalized breast cell line, KAIMRC1 with a potential to play a key role in opening up novel avenues towards the understanding of breast carcinoma.

Indexed as

Breast NeoplasmsCell Culture TechniquesCell Line, TumorCell ProliferationFemaleHumansMAP Kinase Signaling SystemMCF-7 CellsMiddle AgedNeoplasm StagingBRCA1BRCA2Breast cancerCell lineCharacterizationDrug treatmentGene expressionImmortalizationIsolationNatural transformation

Identifiers

PMID29187162
PMCPMC5707794
OpenAlexW2770776365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.